Login / Signup
Marise R Heerma van Voss
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Locally Advanced
Radical Prostatectomy
Prognostic Factors
Ejection Fraction
Top Venues
Cancer chemotherapy and pharmacology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Marise R Heerma van Voss
,
Jessica C L Notohardjo
,
Joyce M van Dodewaard-de Jong
,
Haiko J Bloemendal
,
Rob Ter Heine
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients.
Cancer chemotherapy and pharmacology
(2024)
Marise R Heerma van Voss
,
Jessica C L Notohardjo
,
Joyce M van Dodewaard-de Jong
,
Haiko J Bloemendal
,
Rob Ter Heine
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients.
Cancer chemotherapy and pharmacology
(2024)
Marise R Heerma van Voss
,
Jessica C L Notohardjo
,
Joyce M van Dodewaard-de Jong
,
Haiko J Bloemendal
,
Rob Ter Heine
A sub-pharmacological test dose does not predict individual docetaxel exposure in prostate cancer patients.
Cancer chemotherapy and pharmacology
(2024)